HC Wainwright & Co. Reiterates Buy on Rallybio, Maintains $6 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Mitchell Kapoor has reiterated a Buy rating for Rallybio (NASDAQ:RLYB) and maintained a price target of $6.
October 01, 2024 | 10:13 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
HC Wainwright & Co. has reiterated a Buy rating for Rallybio, maintaining a $6 price target, indicating confidence in the company's potential growth.
The reiteration of a Buy rating and maintenance of a $6 price target by a reputable analyst suggests confidence in Rallybio's future performance, likely leading to positive investor sentiment and potential short-term price increase.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100